CLEVELAND, Ohio — The Cleveland Clinic has named Dr. Eric Klein as chairman of its Glickman Urological and Kidney institute.
Klein succeeds his longtime mentor, Dr. Andrew Novick, who died from complications of cancer in October.
Klein is a leader in the biology and management of prostate cancer. His clinical interest is the study of urologic cancers, including those of the prostate, bladder, testis and kidney. He also is well regarded for his reconstructive surgeries.
“As a national and international expert in his field, Eric is well-positioned to further expand the institute’s reputation for medical and surgical advancements while fostering an environment of collaboration,” said Dr. Joseph Hahn, Cleveland Clinic chief of staff, in a written statement.
Klein had been interim chairman of the Glickman Institute since the untimely passing of Novick.
“I’m humbled and honored to be able to lead such a distinguished group of people who are truly committed to uncovering new, innovative treatments and delivering the best outcomes for our patients,” Klein said in the statement.